49 PRIMECAP Management Abbott Laboratories Trades
PRIMECAP Management's position in Abbott Laboratories is currently worth $118 Million. That's 0.09% of their equity portfolio (128th largest holding). The first Abbott Laboratories trade was made in Q1 2013. Since then PRIMECAP Management bought shares eight more times and sold shares on 40 occasions. The stake costed the investor $30.7 Million, netting the investor a gain of 283% so far.
News about Abbott Laboratories and PRIMECAP Management
Smithbridge Asset Management Inc. DE Buys 513 Shares of Abbott Laboratories (NYSE:ABT)
Smithbridge Asset Management Inc. DE grew its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.1% in the third quarter, according to its ...
Summit Financial Group Inc. Lowers Position in Abbott Laboratories (NYSE:ABT)
… at approximately $28,000. Financial Gravity Asset Management Inc. … during the first quarter. Financial Gravity Asset Management Inc. … the last quarter. H...
Dechtman Wealth Management LLC Makes New $406,000 Investment in Abbott Laboratories (NYSE:ABT)
… Analysis on ABT About Abbott Laboratories (Free Report) Abbott Laboratories , together with its … in four segments: Established Pharmaceutical Products, Di...
HB Wealth Management LLC Has $8.61 Million Holdings in Abbott Laboratories (NYSE:ABT)
HB Wealth Management LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 7.6% in the third quarter, according to its most re...